MHRA Investigates GMP Deficiency Trends From 2016
By Zachary Brennan -
Published 18 April 2017
The UK’s Medicines & Healthcare products Regulatory Agency (MHRA) on Tuesday released a new report on the trends seen from inspecting pharmaceutical manufacturing plants and evaluating their good manufacturing practices (GMPs).
Categories: News, Europe, MHRA, Government affairs, Manufacturing, Regulatory intelligence, Regulatory strategy
Tags: GMP deficiencies, pharmaceutical inspections, GMP deficiency trends